+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 35Years
FEMALE
ID06793904

Study Comparing Two Insulin Resistance Tests to Predict Ovulation Results in Women With Polycystic Ovarian Syndrome Using Letrozole Treatment

Led by Cairo University · Updated on 2025-02-05

122

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying women diagnosed with Polycystic Ovarian Syndrome PCOS who are seeking to conceive. The study compares two methods of measuring insulin resistance, called HOMA1-IR and HOMA2-IR, to see how well they predict ovulation outcomes. The research is conducted as a prospective cohort study with 122 women at a fertility clinic. All participants will receive an ovulation induction treatment using the aromatase inhibitor Letrozole, taken as 2.5 mg tablets twice daily starting on the third day of their menstrual cycle for five days. Ultrasound monitoring will be performed to track follicle growth until the dominant follicle reaches 18 to 22 mm. Additional follicle-stimulating hormone FSH injections will be given if needed. During the study, participants will have their insulin resistance calculated by two different methods using blood glucose and insulin levels. The main outcome measured is the number of women who successfully ovulate within five days after treatment. The study involves ultrasound exams, blood tests, and close monitoring of ovulation response. The total participation age range is 18 to 35 years, sponsored by Cairo University.

CONDITIONS

Brief Title

Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS

Research Team

A

Ahmed Maged, MD

A

Ahmed Chamel, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here